Chemoinformaics analysis of frangula-emodin-anthrone
| Molecular Weight | 256.257 | nRot | 0 |
| Heavy Atom Molecular Weight | 244.161 | nRig | 16 |
| Exact Molecular Weight | 256.074 | nRing | 3 |
| Solubility: LogS | -3.369 | nHRing | 0 |
| Solubility: LogP | 3.718 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 2 |
| nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 12 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 36.2595 |
| nHD | 3 | BPOL | 12.9065 |
| QED | 0.466 |
| Synth | 2.567 |
| Natural Product Likeliness | 1.164 |
| NR-PPAR-gamma | 0.973 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.011 |
| Pgp-sub | 0.006 |
| HIA | 0.113 |
| CACO-2 | -5.127 |
| MDCK | 0.00000567 |
| BBB | 0.012 |
| PPB | 0.972633 |
| VDSS | 0.534 |
| FU | 0.0351575 |
| CYP1A2-inh | 0.986 |
| CYP1A2-sub | 0.618 |
| CYP2c19-inh | 0.143 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.595 |
| CYP2c9-sub | 0.82 |
| CYP2d6-inh | 0.563 |
| CYP2d6-sub | 0.354 |
| CYP3a4-inh | 0.169 |
| CYP3a4-sub | 0.083 |
| CL | 11.092 |
| T12 | 0.877 |
| hERG | 0.03 |
| Ames | 0.629 |
| ROA | 0.219 |
| SkinSen | 0.956 |
| Carcinogencity | 0.088 |
| EI | 0.952 |
| Respiratory | 0.611 |
| NR-Aromatase | 0.048 |
| Antiviral | Yes |
| Prediction | 0.705816 |